Efficacy and safety of sorafenib in patients with alcohol-related hepatocellular carcinoma: A sub-analysis from the SHARP trial

被引：0

作者：

Craxi, A.

Porta, C.

Sangiovanni, A.

Seitz, J.

Moscovici, M.

Shan, M.

Nadel, A.

Voliotis, D.

Bruix, J.

Llovet, J. M.

机构：

[1] Univ Palermo, Acad Dept Med, Palermo, Italy

[2] IRCCS San Matteo Univ Hosp Fdn, Pavia, Italy

[3] Fdn IRCCS Osped Maggiore Policlin, Milan, Italy

[4] Univ Aix Marseille 2, CHU Timon, Marseille, France

[5] Bayer Schering Pharma, Milan, Italy

[6] Bayer HealthCare Pharmaceut, West Haven, CT USA

[7] Bayer Schering Pharma, Wuppertal, Germany

[8] Barcelona Clin, Liver Canc Grp, Barcelona, Spain

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

15591

引用

页数：1